COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
Dapoxetine hydrochloride (HB1788)
Description:Selective serotonin reuptake inhibitor (SSRI)
Purity:>99%
-
-
-
(S)-Duloxetine hydrochloride (HB1806)
Description:Potent 5-HT and NA reuptake inhibitor. Also inhibits dopamine reuptake.
Purity:>99%
-
Escitalopram oxalate (HB1804)
Description:Selective serotonin reuptake inhibitor (SSRI)
Purity:>99%
-
-
Fluoxetine hydrochloride (HB1600)
Description:Selective 5-HT uptake inhibitor. Affects differentiation of NSCs.
Purity:>98%
-
Fluvoxamine maleate (HB2138)
Description:Selective serotonin reuptake inhibitor and σ1 receptor agonist
Purity:>98%
-
GBR 12909 dihydrochloride (HB1812)
Description:Potent, competitive dopamine uptake inhibitor
Purity:>98%
-
ITD 1 (HB3446)
Description:Selective TGF-β signaling inhibitor. Induces cardiomyocyte differentiation in ESCs.
Purity:>98%
